CymaBay Therapeutics, Inc. Recorded Big Gain
Tue, Nov 26, 2019 at 05:30 PM
CymaBay Therapeutics, Inc. (CBAY:NASDAQ) rocketted at $1.66, representing a gain of 24.8%. On Mon 25 Nov 19, CBAY:NASDAQ hit a New 2-Week Low of $1.33. The stock appeared on our News Catalysts scanner on Tue 26 Nov 19 at 01:02 PM in the 'BIOTECH' category. From Tue 05 Nov 19, the stock recorded 50.00% Up Days and 40.00% Green Days
About CymaBay Therapeutics, Inc. (CBAY:NASDAQ)
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 281.27%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.44%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 48.78%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 43.75%
- SG Blocks, Inc. (SGBX:NASDAQ), 29.62%
- China Ceramics Co., Ltd. (CCCL:NASDAQ), 29.17%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 28.69%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 26.98%
- Akerna Corp. (KERN:NASDAQ), 26.59%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 24.81%